Kymera Therapeutics (KYMR) Long-Term Investments (2020 - 2025)
Historic Long-Term Investments for Kymera Therapeutics (KYMR) over the last 6 years, with Q3 2025 value amounting to $473.1 million.
- Kymera Therapeutics' Long-Term Investments rose 3103.99% to $473.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $473.1 million, marking a year-over-year increase of 3103.99%. This contributed to the annual value of $362.2 million for FY2024, which is 48957.58% up from last year.
- According to the latest figures from Q3 2025, Kymera Therapeutics' Long-Term Investments is $473.1 million, which was up 3103.99% from $297.6 million recorded in Q2 2025.
- Over the past 5 years, Kymera Therapeutics' Long-Term Investments peaked at $473.1 million during Q3 2025, and registered a low of $45.3 million during Q2 2021.
- In the last 5 years, Kymera Therapeutics' Long-Term Investments had a median value of $113.7 million in 2022 and averaged $175.4 million.
- In the last 5 years, Kymera Therapeutics' Long-Term Investments crashed by 6015.23% in 2021 and then surged by 48957.58% in 2024.
- Kymera Therapeutics' Long-Term Investments (Quarter) stood at $125.2 million in 2021, then increased by 21.67% to $152.3 million in 2022, then plummeted by 59.67% to $61.4 million in 2023, then soared by 489.58% to $362.2 million in 2024, then soared by 30.62% to $473.1 million in 2025.
- Its Long-Term Investments stands at $473.1 million for Q3 2025, versus $297.6 million for Q2 2025 and $312.3 million for Q1 2025.